CMV infection in glioblastoma leads to shortened overall survival and TMZ resistance in vitro and in vivo

CMV infection in glioblastoma leads to shortened overall survival and TMZ resistance in vitro and in vivo

Bibliographic Details
Main Authors:	H. Krenzlin, P. Einheuser, F. Corr, F. Ringel, N. Keric
Format:	Article
Language:	English
Published:	Elsevier 2022-01-01
Series:	Brain and Spine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772529422004052

Similar Items

CMV infection in glioblastoma - Oncomodulation through changes to the glioma immune landscape
by: Harald Krenzlin, et al.
Published: (2023-01-01)

Longitudinal analysis of the immune landscape in recurrent glioblastoma – Infiltration of Natural killer cells and TCR clonality as biomarkers of overall survival
by: Harald Krenzlin, et al.
Published: (2023-01-01)

Mechanisms of cytomegalovirus to tumor transmission across the blood brain barrier in glioblastoma
by: H. Krenzlin, et al.
Published: (2022-01-01)

Regorafenib- A feasible option as third-line therapy of recurrent glioblastoma?
by: Alice Dauth, et al.
Published: (2023-01-01)

Clinical activity and safety of sintilimab, bevacizumab, and TMZ in patients with recurrent glioblastoma
by: Yinghao Lu, et al.
Published: (2024-01-01)

Dysregulated lipid metabolism in TMZ-resistant glioblastoma: pathways, proteins, metabolites and therapeutic opportunities
by: Tzu-Jen Kao, et al.
Published: (2023-08-01)

Gasdermin D Is a Novel Prognostic Biomarker and Relates to TMZ Response in Glioblastoma
by: Junhui Liu, et al.
Published: (2021-11-01)

Suppression of ITPKB degradation by Trim25 confers TMZ resistance in glioblastoma through ROS homeostasis
by: Yuanliang Yan, et al.
Published: (2024-03-01)

Enhanced Sensitivity to ALDH1A3-Dependent Ferroptosis in TMZ-Resistant Glioblastoma Cells
by: Yang Wu, et al.
Published: (2023-10-01)

317 Omics based analysis to identify novel markers of TMZ response in Glioblastoma Multiforme
by: Megan R. Reed, et al.
Published: (2023-04-01)

Impact of sarcopenia and bone density on implant failure and adjacent level degeneration in lumbar instrumentation
by: H. Krenzlin, et al.
Published: (2022-01-01)

Impact of sarcopenia, obesity and bone mineral density on implant failure after spondylodesis in patients with osteoporotic vertebral fractures
by: H. Krenzlin, et al.
Published: (2022-01-01)

Intermodal Detection of Lumbar Instability in Degenerative Spondylolisthesis is Superior to Functional Radiographs
by: Harald Krenzlin, et al.
Published: (2022-06-01)

Identification of miRNA signature associated with BMP2 and chemosensitivity of TMZ in glioblastoma stem-like cells
by: Xiaoyu Guo, et al.
Published: (2020-09-01)

Telomere length shortening in CML is associated with reduced time to accelerated phase but does not influence overall survival.
by: Boultwood, J, et al.
Published: (1999)

Influence of frailty and sarcopenia on long-term neurological outcome in patients with aneurysmatic subarachnoid hemorrhage.
by: Dragan Jankovic, et al.
Published: (2023-01-01)

Involvement of Cyclooxygenase-2 in Establishing an Immunosuppressive Microenvironment in Tumorspheres Derived from TMZ-Resistant Glioblastoma Cell Lines and Primary Cultures
by: Francesca Lombardi, et al.
Published: (2024-01-01)

Up-Regulation of Cyclooxygenase-2 (COX-2) Expression by Temozolomide (TMZ) in Human Glioblastoma (GBM) Cell Lines
by: Francesca Lombardi, et al.
Published: (2022-01-01)

PSMA Expression Correlates with Improved Overall Survival and VEGF Expression in Glioblastoma
by: Alexander Yuile, et al.
Published: (2023-04-01)

A comparative observational analysis of PMMA versus CaP titanium-enhanced implants for cranioplasty after decompressive craniectomy
by: D.M.A. Wesp, et al.
Published: (2022-01-01)

Systemic Administration of Argatroban Reduces Secondary Brain Damage in a Mouse Model of Intracerebral Hemorrhage
by: Harald Krenzlin, et al.
Published: (2023-01-01)

Successful Partnerships: Exploring the Potential of Immunogenic Signals Triggered by TMZ, CX-4945, and Combined Treatment in GL261 Glioblastoma Cells
by: Lucía Villamañan, et al.
Published: (2021-03-01)

TMZ-BioShuttle – a reformulated Temozolomide
by: Waldemar Waldeck, Manfred Wiessler, Volker Ehemann, Ruediger Pipkorn, Herbert Spring, Juergen Debus, Bernd Didinger, Gabriele Mueller, Joerg Langowski, Klaus Braun
Published: (2008-01-01)

Ex Vivo Expanded and Activated Natural Killer Cells Prolong the Overall Survival of Mice with Glioblastoma-like Cell-Derived Tumors
by: Yoichi Shida, et al.
Published: (2021-09-01)

Local administration of shikonin improved the overall survival in orthotopic murine glioblastoma models with temozolomide resistance
by: Ryosuke Maeoka, et al.
Published: (2023-10-01)

Overall avidity declines in TCR repertoires during latent CMV but not EBV infection
by: Barbara Couturaud, et al.
Published: (2023-11-01)

An assessment of predictive factors for overall survival in glioblastoma – MGMT methylation is solely important for younger patients
by: T. Cosar, et al.
Published: (2022-01-01)

Association of graph-based spatial features with overall survival status of glioblastoma patients
by: Joonsang Lee, et al.
Published: (2023-10-01)

Machine Learning and Radiomic Features to Predict Overall Survival Time for Glioblastoma Patients
by: Lina Chato, et al.
Published: (2021-12-01)

Experimental study of selective MGMT peptides mimicking TMZ drug resistance in glioma
by: Yue Wu, et al.
Published: (2022-12-01)

Glioblastoma: A Retrospective Analysis of the Role of the Maximal Surgical Resection on Overall Survival and Progression Free Survival
by: Gabriele Polonara, et al.
Published: (2023-03-01)

Co-administration of temozolomide (TMZ) and the experimental therapeutic targeting miR-10b, profoundly affects the tumorigenic phenotype of human glioblastoma cells
by: Ming Chen, et al.
Published: (2023-06-01)

Shortening of Overall Orthodontic Treatment Duration with Low-Intensity Pulsed Ultrasound (LIPUS)
by: Harmanpreet Kaur, et al.
Published: (2020-05-01)

Impact of Sarcopenia and Bone Mineral Density on Implant Failure after Dorsal Instrumentation in Patients with Osteoporotic Vertebral Fractures
by: Harald Krenzlin, et al.
Published: (2022-05-01)

Old and new systemic immune-inflammation indexes are associated with overall survival of glioblastoma patients treated with radio-chemotherapy
by: Pasqualetti, F, et al.
Published: (2022)

Effect of Zinc Sulfate on Overall Survival and Progression-Free Survival in Patients with Glioblastoma Multiforme, a Phase II Study
by: Niloofar Ahmadloo, et al.
Published: (2023-01-01)

Immune System-Related Changes in Preclinical GL261 Glioblastoma under TMZ Treatment: Explaining MRSI-Based Nosological Imaging Findings with RT-PCR Analyses
by: Pilar Calero-Pérez, et al.
Published: (2021-05-01)

Tumor-neutrophil crosstalk promotes in vitro and in vivo glioblastoma progression
by: Dominique S. Rubenich, et al.
Published: (2023-05-01)

Novel Biodegradable Composite of Calcium Phosphate Cement and the Collagen I Mimetic P-15 for Pedicle Screw Augmentation in Osteoporotic Bone
by: Harald Krenzlin, et al.
Published: (2021-10-01)

Postoperative Monitoring On ICU After Elective Craniotomies: How Much Monitoring Is Required?
by: Elena Kurz, et al.
Published: (2023-01-01)